METABOLIC & WEIGHT LOSS STACK
Semaglutide + CagrilintideGLP-1 agonist + amylin analog (CagriSema)
Synergy: This is the molecular basis of the CagriSema combination drug. Semaglutide activates GLP-1 receptors; Cagrilintide activates amylin receptors. Phase 3 REDEFINE-1 showed approximately 22.7% mean body weight loss at 68 weeks.
Stack components
Semaglutide
Metabolic & Weight
GLP-1 receptor agonist for blood sugar control and significant weight reduction.
0.25 mg draw on 100u syringe
Cagrilintide
Metabolic & Weight
Long-acting amylin analog promoting satiety. Combined with semaglutide (CagriSema), REDEFINE-1 showed ~22.7% weight loss.
0.3 mg draw on 100u syringe
Injection timing
Both once weekly SC.
Same syringe or separate?
In commercial CagriSema, both are co-formulated. In research compound use, they are typically drawn separately for accurate independent titration.
Typical cycle length
Titration over 17+ weeks to 2.4/2.4 mg maintenance.
Research use only. Peptide stacks compound effects and side-effect risk. Always verify Certificates of Analysis for each peptide. Consult a qualified clinician before initiating any combined protocol.
Open the calculators
Frequently asked
What does the Semaglutide + Cagrilintide stack do?
This is the molecular basis of the CagriSema combination drug. Semaglutide activates GLP-1 receptors; Cagrilintide activates amylin receptors. Phase 3 REDEFINE-1 showed approximately 22.7% mean body weight loss at 68 weeks.
When should Semaglutide and Cagrilintide be injected?
Both once weekly SC.
Can Semaglutide and Cagrilintide be drawn into the same syringe?
In commercial CagriSema, both are co-formulated. In research compound use, they are typically drawn separately for accurate independent titration.
How long is a typical Semaglutide + Cagrilintide cycle?
Titration over 17+ weeks to 2.4/2.4 mg maintenance.
What dose of Semaglutide pairs with Cagrilintide?
Standard ASCEND reference dose for Semaglutide: 0.25 mg from a 5 mg vial reconstituted with 1 mL bacteriostatic water (5 mg/mL). Draw volume at this concentration: 0.05 mL, which is 5 IU on a 100-unit insulin syringe. Adjust to the research protocol you are following.
Related
For research informational use only. Not medical advice. Combination protocols have not been formally validated by the FDA. Consult a qualified healthcare provider before initiating any peptide stack.